Galectin Therapeutics remains a buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints. The FDA’s endorsement of a single, well-controlled Phase 3 trial with ...
Abstract: Graph representations convert large-scale Automatic Identification System (AIS) trajectories into a routable network, enabling maritime path planning to be posed as a constrained ...
Abstract: The continuous development of mobile terminal applications, online maps, and other navigation services have become widely used, simultaneously giving rise to significant security risks. To ...
Conclusions: This study represents a pioneering effort in using LLMs, particularly GPT-4.0, to construct a comprehensive sepsis knowledge graph. The innovative application of prompt engineering, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results